Global Human Rabies Vaccines Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 96

Report ID: 22350

Rabies vaccine is a vaccine used to prevent rabies.They can be used to prevent rabies before and for a period of time after exposure to the virus such as by a dog or bat bite.The immunity that develops is long lasting after a full course.
Global human rabies vaccines market is expected to witness robust growth over the forecast period. Increasing global incidences of mortality due to rabies, growing issue of stray dogs in countries with low economic development, rising number of pets, lack of pet management services, low immunization rates in pets, and rising friendliness with pets are drivers estimated to boost growth of human rabies vaccine market.

The global Human Rabies Vaccines market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Human Rabies Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Rabies Vaccines market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Sanofi Pasteur,Inc.
Novartis Vaccines and Diagnostics Ltd.
Cadila Pharmaceuticals Ltd.
GlaxoSmithKline Biologicals
Merck&Co Inc.
Wyeth pharmaceuticals
Berna Biotech Ltd.
Medimmune LLC

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others

Segment by Application
Pre-Exposure Prophylaxis
Post-Exposure Prophylaxis

Table of Contents

Executive Summary
1 Human Rabies Vaccines Market Overview
1.1 Product Overview and Scope of Human Rabies Vaccines
1.2 Human Rabies Vaccines Segment by Type
1.2.1 Global Human Rabies Vaccines Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Vero Cell Rabies Vaccine
1.2.3 BHK
1.2.4 Chick Embryo Cell Rabies Vaccine
1.2.5 Others
1.3 Human Rabies Vaccines Segment by Application
1.3.1 Human Rabies Vaccines Consumption Comparison by Application (2014-2025)
1.3.2 Pre-Exposure Prophylaxis
1.3.3 Post-Exposure Prophylaxis
1.4 Global Human Rabies Vaccines Market by Region
1.4.1 Global Human Rabies Vaccines Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Human Rabies Vaccines Market Size
1.5.1 Global Human Rabies Vaccines Revenue (2014-2025)
1.5.2 Global Human Rabies Vaccines Production (2014-2025)

2 Global Human Rabies Vaccines Market Competition by Manufacturers
2.1 Global Human Rabies Vaccines Production Market Share by Manufacturers (2014-2019)
2.2 Global Human Rabies Vaccines Revenue Share by Manufacturers (2014-2019)
2.3 Global Human Rabies Vaccines Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Human Rabies Vaccines Production Sites, Area Served, Product Types
2.5 Human Rabies Vaccines Market Competitive Situation and Trends
2.5.1 Human Rabies Vaccines Market Concentration Rate
2.5.2 Human Rabies Vaccines Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Human Rabies Vaccines Production Market Share by Regions
3.1 Global Human Rabies Vaccines Production Market Share by Regions
3.2 Global Human Rabies Vaccines Revenue Market Share by Regions (2014-2019)
3.3 Global Human Rabies Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Human Rabies Vaccines Production
3.4.1 North America Human Rabies Vaccines Production Growth Rate (2014-2019)
3.4.2 North America Human Rabies Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Human Rabies Vaccines Production
3.5.1 Europe Human Rabies Vaccines Production Growth Rate (2014-2019)
3.5.2 Europe Human Rabies Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Human Rabies Vaccines Production (2014-2019)
3.6.1 China Human Rabies Vaccines Production Growth Rate (2014-2019)
3.6.2 China Human Rabies Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Human Rabies Vaccines Production (2014-2019)
3.7.1 Japan Human Rabies Vaccines Production Growth Rate (2014-2019)
3.7.2 Japan Human Rabies Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Human Rabies Vaccines Consumption by Regions
4.1 Global Human Rabies Vaccines Consumption by Regions
4.2 North America Human Rabies Vaccines Consumption (2014-2019)
4.3 Europe Human Rabies Vaccines Consumption (2014-2019)
4.4 China Human Rabies Vaccines Consumption (2014-2019)
4.5 Japan Human Rabies Vaccines Consumption (2014-2019)

5 Global Human Rabies Vaccines Production, Revenue, Price Trend by Type
5.1 Global Human Rabies Vaccines Production Market Share by Type (2014-2019)
5.2 Global Human Rabies Vaccines Revenue Market Share by Type (2014-2019)
5.3 Global Human Rabies Vaccines Price by Type (2014-2019)
5.4 Global Human Rabies Vaccines Production Growth by Type (2014-2019)

6 Global Human Rabies Vaccines Market Analysis by Applications
6.1 Global Human Rabies Vaccines Consumption Market Share by Application (2014-2019)
6.2 Global Human Rabies Vaccines Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Human Rabies Vaccines Business
7.1 Sanofi Pasteur,Inc.
7.1.1 Sanofi Pasteur,Inc. Human Rabies Vaccines Production Sites and Area Served
7.1.2 Human Rabies Vaccines Product Introduction, Application and Specification
7.1.3 Sanofi Pasteur,Inc. Human Rabies Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Novartis Vaccines and Diagnostics Ltd.
7.2.1 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Production Sites and Area Served
7.2.2 Human Rabies Vaccines Product Introduction, Application and Specification
7.2.3 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Cadila Pharmaceuticals Ltd.
7.3.1 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Production Sites and Area Served
7.3.2 Human Rabies Vaccines Product Introduction, Application and Specification
7.3.3 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 GlaxoSmithKline Biologicals
7.4.1 GlaxoSmithKline Biologicals Human Rabies Vaccines Production Sites and Area Served
7.4.2 Human Rabies Vaccines Product Introduction, Application and Specification
7.4.3 GlaxoSmithKline Biologicals Human Rabies Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Merck&Co Inc.
7.5.1 Merck&Co Inc. Human Rabies Vaccines Production Sites and Area Served
7.5.2 Human Rabies Vaccines Product Introduction, Application and Specification
7.5.3 Merck&Co Inc. Human Rabies Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Wyeth pharmaceuticals
7.6.1 Wyeth pharmaceuticals Human Rabies Vaccines Production Sites and Area Served
7.6.2 Human Rabies Vaccines Product Introduction, Application and Specification
7.6.3 Wyeth pharmaceuticals Human Rabies Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Berna Biotech Ltd.
7.7.1 Berna Biotech Ltd. Human Rabies Vaccines Production Sites and Area Served
7.7.2 Human Rabies Vaccines Product Introduction, Application and Specification
7.7.3 Berna Biotech Ltd. Human Rabies Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Medimmune LLC
7.8.1 Medimmune LLC Human Rabies Vaccines Production Sites and Area Served
7.8.2 Human Rabies Vaccines Product Introduction, Application and Specification
7.8.3 Medimmune LLC Human Rabies Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served

8 Human Rabies Vaccines Manufacturing Cost Analysis
8.1 Human Rabies Vaccines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Human Rabies Vaccines
8.4 Human Rabies Vaccines Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Human Rabies Vaccines Distributors List
9.3 Human Rabies Vaccines Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Human Rabies Vaccines Market Forecast
11.1 Global Human Rabies Vaccines Production, Revenue Forecast
11.1.1 Global Human Rabies Vaccines Production Growth Rate Forecast (2019-2025)
11.1.2 Global Human Rabies Vaccines Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Human Rabies Vaccines Price and Trend Forecast (2019-2025)
11.2 Global Human Rabies Vaccines Production Forecast by Regions (2019-2025)
11.2.1 North America Human Rabies Vaccines Production, Revenue Forecast (2019-2025)
11.2.2 Europe Human Rabies Vaccines Production, Revenue Forecast (2019-2025)
11.2.3 China Human Rabies Vaccines Production, Revenue Forecast (2019-2025)
11.2.4 Japan Human Rabies Vaccines Production, Revenue Forecast (2019-2025)
11.3 Global Human Rabies Vaccines Consumption Forecast by Regions (2019-2025)
11.3.1 North America Human Rabies Vaccines Consumption Forecast (2019-2025)
11.3.2 Europe Human Rabies Vaccines Consumption Forecast (2019-2025)
11.3.3 China Human Rabies Vaccines Consumption Forecast (2019-2025)
11.3.4 Japan Human Rabies Vaccines Consumption Forecast (2019-2025)
11.4 Global Human Rabies Vaccines Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Human Rabies Vaccines Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer